Studio Bakaliesp. z o.o.
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2006-12-19
Share capital
50,000.00 PLN
Registered address
Makolągwy 23 E/5, 02-811 Warszawa, Poland
Financials
Filing timeliness
No financial statement for 2019 – the filing deadline has passed. 1 of 1 financial statements was filed late (for 2018, 116 days late).
- 2019not filed
- 201808/11/2019
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2018.
Results vs industry
Revenue
This companyUSD 19.45kMedianUSD 561.73kAverageUSD 765.08k
Net profit
This companyUSD 8.96kMedianUSD 21.77kAverageUSD 30.89k
Operating costs
This companyUSD 10.49kMedianUSD 512.92kAverageUSD 724.16k
Assets
This companyUSD 7.40kMedianUSD 419.73kAverageUSD 559.39k
Industry
Trademarks
Studio Bakalie currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2009.
| Mark | Protected until | |
|---|---|---|
| bakalie studio brandingowe | – |
Authorized Representatives
Piotr Domownik – Management Board Member
Manner of representation
Each member of the management board independently, or a commercial proxy independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Piotr Domownikage 56 | 50 | $6,753.11 | 50% |
Justyna Danuta Dziewięckaage 55 | 50 | $6,753.11 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2007-01-24.
54 1240 1125 1111 0010 7141 7843
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com |
Change history
| Date | Event | |
|---|---|---|
| 2010-11-18 | Address change (Racławicka 99, 02-634, Warszawa → Makolągwy 23 E/5, 02-811, Warszawa) | |
| 2006-12-19 | Entered in the register |
FAQ
The company was registered in the Polish National Court Register (KRS) on December 19, 2006.
The headquarters is located at: Makolągwy 23 E, 02-811 Warszawa.
The management board consists of: Piotr Domownik (Member of the Management Board).
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2018 to December 31, 2018.
In 2018, the company's revenue reached $19,445.
Yes, in 2018 the company was profitable, achieving a net profit of $8,955.
The largest operating cost category falls under external services. This category amounted to $7,416 in 2018, representing 71% of all operating expenses.
Last updated: 2026-04-14